Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-23

FDA Approved: UBRELVY — Original Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved UBRELVY (ubrogepant) from Allergan, Inc. as the original application for the acute treatment of migraine in adults. The approval covers treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ubrelvy (ubrogepant)

Snippet

ORIG AP for UBRELVY (UBROGEPANT)